Skip to main content

Table 1 Baseline characteristics of the GR group vs. the non-GR group in congenital diaphragmatic hernia

From: Prevalence and perinatal risk factors of growth retardation in congenital diaphragmatic hernia survivors

 

GR

(N = 20)

Non-GR

(N = 57)

p-value

Gestational age (week)

38.0 ± 1.2

38.4 ± 1.1

0.142

Birth weight (gram)

2676 ± 578.6

3094 ± 383.9

0.003

Length (cm)

47.5 ± 3.5

49.3 ± 1.9

0.065

Male

11 (55.0%)

32 (56.1%)

0.930

Caesarean section

12 (60.0%)

36 (63.2%)

0.802

O/E LHR (tracing)

55.4 ± 15.3

61.0 ± 17.2

0.203

Laterality (right)

6 (30.0%)

7 (12.3%)

0.069

Liver herniation

9 (45.0%)

15 (26.3%)

0.121

Late preterm

5 (25.0%)

6 (10.5%)

0.141

Low birth weight

7 (35.0%)

3 (5.3%)

0.002

Small for gestational age

5 (25.0%)

2 (3.5%)

0.011

Use of ECMO

4 (20.0%)

4 (7.0%)

0.102

Use of iNO

9 (45.0%)

14 (24.6%)

0.086

Use of HFOV

15 (75.0%)

20 (64.9%)

0.407

Use of any inotropes

19 (95.0%)

41 (71.9%)

0.056

Use of corticosteroid

11 (55.0%)

16 (28.1%)

0.030

Hydrocortisone

11 (55.0%)

15 (26.3%)

0.039

Dexamethasone

2 (10.0%)

2 (3.5%)

0.589

Thoracoscopic surgery

10 (50.0%)

39 (68.4%)

0.141

Patch repair

8 (40.0%)

19 (33.3%)

0.591

Tube feeding at discharge, %

3 (15.0%)

3 (5.3%)

0.162

Length of hospital stay

43.4 ± 32.5

30.8 ± 16.1

0.067

BPD at 30 days

7 (35.0%)

14 (24.6%)

0.367

PHT medication at discharge

2 (10.0%)

1 (1.8%)

0.164

Duration of mechanical ventilator

15.6 ± 8.2

13.0 ± 8.6

0.244

Home O2 at discharge

1 (5.0%)

3 (5.3%)

1.000

  1. Data are presented as No. (%) or as mean ± SD. GR = growth retardation, O/E LHR = observed-to-expected lung-to-head ratio, ECMO = extracorporeal membrane oxygenation, iNO = inhaled nitric oxide, HFOV = high frequency oscillatory ventilator, BPD = bronchopulmonary dysplasia, PHT = pulmonary hypertension